Cathie Wood’s ARK Invest Sells Over 225,000 Shares of Takeda Pharma
One of Cathie Wood's Ark Invest funds sold over 225,000 shares of Takeda Pharma on June 15.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
One ARK Invest exchange-traded fund run by ETF star Cathie Wood sold over 225,000 shares of Takeda Pharmaceutical Co. Ltd. (NYSE: TAK) on Tuesday, as the share price of this fund traded down over 2% in the day’s session. The fund’s share price has greatly improved over the past year.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) sold 228,234 shares of Takeda Pharma. At Tuesday’s closing price, this would have valued this sale at roughly $3.9 million. This is only a small fraction of the total holdings. This fund is up 88% over the past 52 weeks.
Here is a quick look at all the other sales that took place across all ARK ETFs:
| Fund | Ticker | Company | Shares |
|---|---|---|---|
| ARKF | TCSLI | TCS GROUP HOLDING PLC | 50,650 |
| ARKG | PSTI | PLURISTEM THERAPEUTICS INC | 1,131 |
| ARKG | NVS | NOVARTIS AG | 139,576 |
| ARKG | SRPT | SAREPTA THERAPEUTICS INC | 48,004 |
| ARKG | TAK | TAKEDA PHARMACEUTICAL CO LTD | 228,234 |
| ARKK | ICE | INTERCONTINENTAL EXCHANGE INC | 196,304 |
| ARKQ | TER | TERADYNE INC | 23,160 |
| ARKQ | RAVN | RAVEN INDUSTRIES INC | 32,733 |
| ARKQ | GLEO | GALILEO ACQUISITION CORP | 5,888 |
| ARKW | NET | CLOUDFLARE INC | 72,257 |
| ARKX | AIRFP | AIRBUS SE | 16,050 |
[nativounit]
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
[recirclink id=896738][wallst_email_signup]
Contact [email protected] for any questions or corrections.







